Results 41 to 50 of about 4,680 (201)

C-type lectin-like receptor 2 in platelets amplifies inflammation in rheumatoid arthritis [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Background: Platelets play a crucial role not only in thrombosis and hemostasis but also in inflammation, including rheumatoid arthritis. Although synovial cells in the joints express the membrane protein podoplanin, and platelets express the podoplanin ...
Tomoyuki Sasaki   +10 more
doaj   +2 more sources

Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. [PDF]

open access: yesBlood, 2015
Key PointsPodoplanin and CLEC-2 critically drive the formation and integrity of developing cerebral blood vessels. Loss of cerebrovascular integrity is influenced by the loss of αIIb-mediated platelet aggregation and platelet secretion.
Lowe KL   +10 more
europepmc   +4 more sources

CLEC-2 expression is maintained on activated platelets and on platelet microparticles. [PDF]

open access: yesBlood, 2014
Key PointsCLEC-2 activation induces proteolytic cleavage of GPVI and FcγRIIa but not itself. CLEC-2 but not GPVI is detected on platelet-derived microparticles.
Gitz E   +12 more
europepmc   +4 more sources

Cobalt hematoporphyrin inhibits CLEC-2–podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice [PDF]

open access: bronzeBlood Adv, 2018
Nagaharu Tsukiji   +12 more
openalex   +2 more sources

The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. [PDF]

open access: yesEur J Immunol, 2015
Expression of mouse C‐type lectin‐like receptor 2 (CLEC‐2) has been reported on circulating CD11b(high) Gr‐1(high) myeloid cells and dendritic cells (DCs) under basal conditions, as well as on a variety of leucocyte subsets following inflammatory stimuli
Lowe KL   +9 more
europepmc   +4 more sources

Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia [PDF]

open access: hybridThromb Haemost, 2018
Alexander T. Hardy   +14 more
openalex   +2 more sources

High‐throughput screen identifies MAS9 as a novel inhibitor of the C‐type lectin receptor‐2 (CLEC‐2)–podoplanin interaction

open access: hybridBritish Journal of Pharmacology, Volume 182, Issue 16, Page 3838-3851, August 2025.
Abstract Background and Purpose The C‐type lectin‐like receptor‐2 (CLEC‐2) is a platelet receptor for the endogenous ligand podoplanin. This interaction contributes to several (patho)physiological processes, such as lymphangiogenesis, preservation of blood and lymphatic vessel integrity organ development, and tumour metastasis.
Marcin A. Sowa   +8 more
openalex   +2 more sources

Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis. [PDF]

open access: yesPLoS ONE, 2015
The platelet receptor CLEC-2 is involved in thrombosis/hemostasis, but its ligand, podoplanin, is expressed only in advanced atherosclerotic lesions. We investigated CLEC-2 ligands in vessel walls.
Osamu Inoue   +9 more
doaj   +1 more source

The Association Between Plasma C-Type Lectin Like Receptors 2 (CLEC-2) and STEMI and its Correlation With Clinicolaboratory Data

open access: yesEgyptian Journal of Critical Care Medicine, 2023
Objectives To assess the association between plasma C-type lectin-like receptor 2 (CLEC-2) and ST elevation myocardial infarction (STEMI) and its correlation with clinicolaboratory data.
Salwa Hassan Ahmed   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy